98 related articles for article (PubMed ID: 11270681)
1. Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats.
Osicka TM; Kiriazis Z; Pratt LM; Jerums G; Comper WD
Diabetologia; 2001 Feb; 44(2):230-6. PubMed ID: 11270681
[TBL] [Abstract][Full Text] [Related]
2. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
[TBL] [Abstract][Full Text] [Related]
3. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
4. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.
Osicka TM; Yu Y; Panagiotopoulos S; Clavant SP; Kiriazis Z; Pike RN; Pratt LM; Russo LM; Kemp BE; Comper WD; Jerums G
Diabetes; 2000 Jan; 49(1):87-93. PubMed ID: 10615954
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effects of a novel inhibitor of advanced glycation.
Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
[TBL] [Abstract][Full Text] [Related]
6. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
Mifsud SA; Allen TJ; Bertram JF; Hulthen UL; Kelly DJ; Cooper ME; Wilkinson-Berka JL; Gilbert RE
Diabetologia; 2001 Jul; 44(7):878-82. PubMed ID: 11508273
[TBL] [Abstract][Full Text] [Related]
7. Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery.
Osicka TM; Yu Y; Lee V; Panagiotopoulos S; Kemp BE; Jerums G
Clin Sci (Lond); 2001 Mar; 100(3):249-57. PubMed ID: 11222110
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction.
Woodman OL; Malakul W; Cao AH; Xu Q; Ritchie RH
Life Sci; 2008 Apr; 82(15-16):847-54. PubMed ID: 18302965
[TBL] [Abstract][Full Text] [Related]
9. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats.
Gül M; Emre S; Eşrefoğlu M; Vard N
Cornea; 2008 Aug; 27(7):795-801. PubMed ID: 18650666
[TBL] [Abstract][Full Text] [Related]
11. Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats.
Osicka TM; Forbes JM; Thallas V; Brammar GC; Jerums G; Comper WD
Nephrology (Carlton); 2003 Aug; 8(4):205-11. PubMed ID: 15012722
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats.
He H; Yang X; Zeng X; Shi M; Yang J; Wu L; Li L
J Pharm Pharmacol; 2007 Sep; 59(9):1297-305. PubMed ID: 17883901
[TBL] [Abstract][Full Text] [Related]
13. Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats.
Mavrakanas TA; Cheva A; Kallaras K; Karkavelas G; Mironidou-Tzouveleki M
Pharmacology; 2010; 86(2):85-91. PubMed ID: 20689340
[TBL] [Abstract][Full Text] [Related]
14. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
Roufail E; Soulis T; Boel E; Cooper ME; Rees S
Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
[TBL] [Abstract][Full Text] [Related]
15. Testis glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase activities in aminoguanidine-treated diabetic rats.
Unlüçerçi Y; Bekpinar S; Koçak H
Arch Biochem Biophys; 2000 Jul; 379(2):217-20. PubMed ID: 10898937
[TBL] [Abstract][Full Text] [Related]
16. L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.
Coronel I; Arellano-Mendoza MG; del Valle-Mondragon L; Vargas-Robles H; Castorena-Torres F; Romo E; Rios A; Escalante B
J Ren Nutr; 2010 May; 20(3):158-68. PubMed ID: 20097580
[TBL] [Abstract][Full Text] [Related]
17. Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats.
Sugimoto K; Yagihashi S
Microvasc Res; 1997 Mar; 53(2):105-12. PubMed ID: 9143541
[TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
Dewhurst M; Omawari N; Tomlinson DR
Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
Huang Y; Lin S; Zhou J
Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of aminoguanidine on the cardiovascular system of diabetic rats.
Stadler K; Jenei V; Somogyi A; Jakus J
Diabetes Metab Res Rev; 2005; 21(2):189-96. PubMed ID: 15386808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
